WO2009111676A3 - Boron-containing small molecules as anti-inflammatory agents - Google Patents
Boron-containing small molecules as anti-inflammatory agents Download PDFInfo
- Publication number
- WO2009111676A3 WO2009111676A3 PCT/US2009/036250 US2009036250W WO2009111676A3 WO 2009111676 A3 WO2009111676 A3 WO 2009111676A3 US 2009036250 W US2009036250 W US 2009036250W WO 2009111676 A3 WO2009111676 A3 WO 2009111676A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- boron
- small molecules
- inflammatory agents
- containing small
- inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Abstract
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020107022132A KR101672511B1 (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
CA 2718170 CA2718170A1 (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
RU2010140803/04A RU2547441C2 (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
KR1020157014083A KR20150065941A (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
NZ58795509A NZ587955A (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
CN2009801162797A CN102014927A (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
AU2009221793A AU2009221793B2 (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
JP2010549900A JP5745279B2 (en) | 2008-01-09 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
MX2010009765A MX2010009765A (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents. |
EP09700012A EP2187893A4 (en) | 2008-03-06 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
BRPI0908565A BRPI0908565A2 (en) | 2008-03-06 | 2009-03-05 | compound, pharmaceutical formulation, methods for reducing the release of a cytokine or chemokine, treating a condition in an animal and inhibiting a phosphodiesterase |
IL207955A IL207955A (en) | 2008-03-06 | 2010-09-02 | Boron-containing small molecules as anti-inflammatory agents |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61/143,700 | 2008-01-09 | ||
US61/148,731 | 2008-01-30 | ||
US3437108P | 2008-03-06 | 2008-03-06 | |
US61/034,371 | 2008-03-06 | ||
US5263708P | 2008-05-12 | 2008-05-12 | |
US61/052,637 | 2008-05-12 | ||
US9440608P | 2008-09-04 | 2008-09-04 | |
US61/094,406 | 2008-09-04 | ||
US10599008P | 2008-10-16 | 2008-10-16 | |
US61/105,990 | 2008-10-16 | ||
US11090308P | 2008-11-03 | 2008-11-03 | |
US61/110,903 | 2008-11-03 | ||
US14370009P | 2009-01-09 | 2009-01-09 | |
US14873109P | 2009-01-30 | 2009-01-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2009111676A2 WO2009111676A2 (en) | 2009-09-11 |
WO2009111676A3 true WO2009111676A3 (en) | 2010-04-01 |
WO2009111676A8 WO2009111676A8 (en) | 2010-09-30 |
Family
ID=41056660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/036250 WO2009111676A2 (en) | 2008-01-09 | 2009-03-05 | Boron-containing small molecules as anti-inflammatory agents |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2187893A4 (en) |
WO (1) | WO2009111676A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1853251B1 (en) | 2005-02-16 | 2013-04-24 | Anacor Pharmaceuticals, Inc. | Halogen-substituted boronophthalides for the treatment of infections |
WO2007078340A2 (en) | 2005-12-30 | 2007-07-12 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
KR20130120552A (en) | 2006-02-16 | 2013-11-04 | 아나코르 파마슈티칼스 인코포레이티드 | Boron-containing small molecules as anti-inflammatory agents |
RU2547441C2 (en) | 2008-03-06 | 2015-04-10 | Анакор Фармасьютикалз, Инк. | Boron-containing small molecules as anti-inflammatory agents |
WO2010028005A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010027975A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010045503A1 (en) | 2008-10-15 | 2010-04-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
EP2378886A4 (en) | 2008-12-17 | 2012-08-29 | Anacor Pharmaceuticals Inc | Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol |
US8343944B2 (en) | 2009-07-28 | 2013-01-01 | Anacor Pharmaceuticals, Inc. | Trisubstituted boron-containing molecules |
US9440994B2 (en) | 2009-08-14 | 2016-09-13 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
WO2011022337A1 (en) | 2009-08-19 | 2011-02-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US8461134B2 (en) | 2009-11-11 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2011063293A1 (en) * | 2009-11-20 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antihelminth agents |
US8716478B2 (en) | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8623911B2 (en) | 2010-03-19 | 2014-01-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
AU2011299243C1 (en) * | 2010-09-07 | 2016-06-02 | Anacor Pharmaceuticals, LLC. | Benzoxaborole derivatives for treating bacterial infections |
SI2744332T1 (en) | 2011-08-19 | 2017-01-31 | Glaxo Group Limited | Benzofuran compounds for the treatment of hepatitis c virus infections |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
DK2950644T3 (en) | 2013-01-30 | 2017-09-04 | Agrofresh Inc | USE OF BENZOXABOROLS AS VOLATIVE ANTIMICROBIAL AGENTS IN MEAT, PLANTS OR PARTS |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
WO2016001834A1 (en) | 2014-07-01 | 2016-01-07 | Daiichi Sankyo Company, Limited | Tricyclic benzoxaboroles as antibacterial agents |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
EP3383363B1 (en) | 2015-11-30 | 2021-01-06 | Anacor Pharmaceuticals, Inc. | Topical pharmaceutical formulations for treating inflammatory-related conditions |
AU2017229098B2 (en) | 2016-03-07 | 2021-05-27 | Agrofresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
US11447506B2 (en) | 2016-05-09 | 2022-09-20 | Anacor Pharmaceuticals, Inc. | Crystal forms of crisaborole in free form and preparation method and use thereof |
WO2017203514A1 (en) * | 2016-05-26 | 2017-11-30 | Perrigo Api Ltd | Polymorphs of crisaborole and production processes therefor |
WO2018160845A1 (en) | 2017-03-01 | 2018-09-07 | Anacor Pharmaceuticals, Inc. | Novel oxaborole analogs and uses thereof |
WO2018207216A1 (en) * | 2017-05-12 | 2018-11-15 | Biophore India Pharmaceuticals Pvt. Ltd. | Novel process for the preparation of 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl) oxy] benzonitrile (crisaborole) |
WO2018216032A1 (en) * | 2017-05-23 | 2018-11-29 | Msn Laboratories Private Limited, R&D Center | Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof |
MX2020005464A (en) | 2017-11-30 | 2020-12-03 | Boragen Inc | Benzoxaborole compounds and formulations thereof. |
AU2019325436B2 (en) | 2018-08-18 | 2023-10-26 | 5Metis, Inc. | Solid forms of substituted benzoxaborole and compositions thereof |
SG11202102674RA (en) | 2018-10-05 | 2021-04-29 | Pfizer | Boron containing pde4 inhibitors |
CN113543852A (en) | 2019-03-06 | 2021-10-22 | 第一三共株式会社 | Pyrrolopyrazole derivatives |
CN112174989B (en) * | 2019-07-02 | 2023-06-20 | 江西同和药业股份有限公司 | Preparation method of clenbuterol |
WO2022043936A1 (en) | 2020-08-31 | 2022-03-03 | Pfizer Inc. | Methods of protecting rna |
WO2024038090A1 (en) * | 2022-08-18 | 2024-02-22 | Mitodicure Gmbh | Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
CN116239498B (en) * | 2023-05-11 | 2023-07-21 | 北京元延医药科技股份有限公司 | Method for preparing clenbuterol intermediate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800845B2 (en) * | 2000-02-22 | 2004-10-05 | Ricoh Company, Ltd. | Multi-beam scanning device, multi-beam scanning method, light source device, and image forming apparatus |
US20060222671A1 (en) * | 2005-03-30 | 2006-10-05 | Astion Development A/S | Dermatological compositions and salts for the treatment of dermatological diseases |
US20070293457A1 (en) * | 2006-02-16 | 2007-12-20 | Baker Stephen J | Boron-containing small molecules as anti-inflammatory agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1853251B1 (en) * | 2005-02-16 | 2013-04-24 | Anacor Pharmaceuticals, Inc. | Halogen-substituted boronophthalides for the treatment of infections |
-
2009
- 2009-03-05 EP EP09700012A patent/EP2187893A4/en not_active Withdrawn
- 2009-03-05 WO PCT/US2009/036250 patent/WO2009111676A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800845B2 (en) * | 2000-02-22 | 2004-10-05 | Ricoh Company, Ltd. | Multi-beam scanning device, multi-beam scanning method, light source device, and image forming apparatus |
US20060222671A1 (en) * | 2005-03-30 | 2006-10-05 | Astion Development A/S | Dermatological compositions and salts for the treatment of dermatological diseases |
US20070293457A1 (en) * | 2006-02-16 | 2007-12-20 | Baker Stephen J | Boron-containing small molecules as anti-inflammatory agents |
Non-Patent Citations (1)
Title |
---|
See also references of EP2187893A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP2187893A2 (en) | 2010-05-26 |
WO2009111676A2 (en) | 2009-09-11 |
EP2187893A4 (en) | 2012-02-22 |
WO2009111676A8 (en) | 2010-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009111676A3 (en) | Boron-containing small molecules as anti-inflammatory agents | |
MX2010009765A (en) | Boron-containing small molecules as anti-inflammatory agents. | |
WO2007095638A3 (en) | Boron-containing small molecules as anti-inflammatory agents | |
WO2010062863A3 (en) | Compositions containing satiogens and methods of use | |
WO2010042548A9 (en) | Methods of treating inflammation | |
WO2008134761A3 (en) | Modification of biological targeting groups for the treatment of cancer | |
WO2007115821A3 (en) | Organic compounds | |
EP2331520A4 (en) | Rosamine derivatives as agents for the treatment of cancer | |
WO2008092099A8 (en) | Compositions and methods for treating hematopoietic malignancies | |
HK1212218A1 (en) | Organoarsenic compounds and methods for the treatment of cancer | |
EP2164515A4 (en) | Method for the treatment of atopic eczema | |
WO2009143078A9 (en) | Methods of treating brain cancer using hexose compounds | |
AU2009223851A8 (en) | Methods of treating hyperacidic disorders | |
AU2008902372A0 (en) | Methods of treatment | |
AU2008906584A0 (en) | Methods of treatment and agents useful for same | |
AU2008902659A0 (en) | Method of Treatment | |
AU2008900291A0 (en) | Method of treatment | |
AU2008904478A0 (en) | Method of treatment | |
AU2008904356A0 (en) | Method of Treatment | |
AU2008903259A0 (en) | Method of treatment | |
AU2007900455A0 (en) | Compounds and Methods of Treatment | |
AU2008905338A0 (en) | Treatment of Solutions or Wastewater | |
AU2008905198A0 (en) | Compositions and Methods for the Prevention and Treatment of Cancer | |
AU2008903693A0 (en) | Compositions and methods for the prevention and treatment of cancer | |
AU2007903139A0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980116279.7 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009700012 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09700012 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010549900 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2718170 Country of ref document: CA Ref document number: MX/A/2010/009765 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009221793 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 587955 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3433/KOLNP/2010 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 20107022132 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010140803 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2009221793 Country of ref document: AU Date of ref document: 20090305 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: PI0908565 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100903 |